Cell-Permeable and Plasma-Stable Peptidomimetic Inhibitors of the Postsynaptic Density-95/N-Methyl-d-Aspartate Receptor Interaction-Reference-Cited by-同舟云学术

Cell-Permeable and Plasma-Stable Peptidomimetic Inhibitors of the Postsynaptic Density-95/N-Methyl-d-Aspartate Receptor Interaction

Published:2011-02-15 Issue:5 Volume:54 Page:1333-1346
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Bach Anders¹,Eildal Jonas N. N.¹,Stuhr-Hansen Nicolai¹,Deeskamp Rasmus¹,Gottschalk Marie¹,Pedersen Søren W.¹,Kristensen Anders S.¹,Strømgaard Kristian¹

Affiliation:

1. Department of Medicinal Chemistry, The Faculty of Pharmaceutical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm1013924

Reference53 articles.

1. Small-molecule inhibitors of protein–protein interactions: progressing towards the dream

2. Reaching for high-hanging fruit in drug discovery at protein–protein interfaces

3. Making protein interactions druggable: targeting PDZ domains

4. New targets for pharmacological intervention in the glutamatergic synapse

5. Targeting PDZ Domain Proteins for Treating NMDA Receptor-Mediated Excitotoxicity

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The crystal structure of N-benzylquinoline-2-carbothioamide, C₁₇H₁₄N₂S;Zeitschrift für Kristallographie - New Crystal Structures;2024-09-06

2. Visible‐Light‐Driven Multicomponent Reactions for the Versatile Synthesis of Thioamides by Radical Thiocarbamoylation;Angewandte Chemie International Edition;2024-08-23

3. Visible‐Light‐Driven Multicomponent Reactions for the Versatile Synthesis of Thioamides by Radical Thiocarbamoylation;Angewandte Chemie;2024-08-23

4. Thioamide construction via sulfur interrupted Brook rearrangement;Green Synthesis and Catalysis;2024-02

5. Rational design of small-sized peptidomimetic inhibitors disrupting protein–protein interaction;RSC Medicinal Chemistry;2024